Back

HFpEF management: state of the art neurohumoral modulation.

28 August 2021 (09:30 - 09:41)
Organised by:
Congress Presentation Part of: How-To manage HFpEF: state of the art in 2021 Chronic Heart Failure ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Scott Solomon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
HFpEF management: state of the art SGLT2 inhibitors.
Professor R. De Boer (Rotterdam, NL)
Video
Presentation thumbnail
HFpEF management: state of the art novel devices.
Professor D. Kaye (Melbourne, AU)
Slides Video
Presentation thumbnail
How-To manage HFpEF: state of the art in 2021 – discussion.
Presentation thumbnail
How-To manage HFpEF: state of the art in 2021 - Chat Moderator.

Access the full session

Session thumbnail
How-To manage HFpEF: state of the art in 2021
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 09:30 CET
You may be interested in
thumbnail
Webinar
Translating the 2021 ESC Guidelines on Heart Failure into our daily practice: where do we stand?
thumbnail
Webinar
Management of heart failure with preserved ejection fraction. ESC 2023 Clinical Practice Guidelines - Webinar Series
thumbnail
ESC TV Today
Episode 20: Among the topics: Healthy nutrition in a nutshell - Indications for catheter ablation of atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources